| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Monday, April 04, 2022 2:36:14 PM
As this plays out the two most likely scenarios are......
1) Info is being leaked that the pill is failing which explains the current state of affairs.
2) The CAN guys dont appreciate that retailers will greatly benefit from their cash injection currently bankrolling Revive and are doing what those types do best, hence the precipitous trending pps.
My bet$$ are heavily on #2, but thats just me!
1) Info is being leaked that the pill is failing which explains the current state of affairs.
2) The CAN guys dont appreciate that retailers will greatly benefit from their cash injection currently bankrolling Revive and are doing what those types do best, hence the precipitous trending pps.
My bet$$ are heavily on #2, but thats just me!
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
